Contact Us

Depomed Headquarters
7999 Gateway Blvd., Suite 300
Newark, CA 94560
Tel: 510.744.8000
Fax: 510.744.8001

Investor Relations
investors@depomed.com

Business Development
busdev@depomed.com

Managed Care
managedmarkets@depomed.com

Patient/ Physician Information

Gralise^® (gabapentin) Tablets, for the management of post-herpetic neuralgia (PHN)
Product hotline: 866.458.6389
Product information: depomed@medcomsol.com
Product website: www.gralise.com

Zipsor^® (diclofenac potassium) Liquid filled capsules, for the relief of mild to moderate acute pain in adults
Product hotline: 866.458.6389
Product information: depomed@medcomsol.com
Product website: www.zipsor.com

Key Facts

Headquarters: Newark, CA

Nasdaq symbol: DEPO

Number of employees: Approx. 275

Marketed Products:

Gralise^® (gabapentin) tablets for the management of Postherpetic Neuralgia (PHN)

Zipsor^® (diclofenac potassium) liquid filled capsules for relief of mild to moderate acute pain

Addressing Important Markets

Postherpetic Neuralgia

Mild to Moderate Acute Pain

Products Marketed By Partners

Glumetza^® (metformin hydrochloride extended-release tablets) by Santarus

Janumet^® XR (sitagliptin/metformin HCl extended-release) tablets by Merck

Nucynta^® ER (tapentadol) extended-release oral tablets by Janssen